Omnipod Sales Soar, But Insulet's Outlook Cut Sparks Stock Selloff
Insulet Corp. (NASDAQ: PODD ) stock traded lower Wednesday after the insulin pump maker reported second-quarter results that topped Wall Street expectations but lowered its full-year revenue guidance and issued third-quarter sales guidance that came in below analysts’ estimates. Adjusted earnings rose to $1.66 per shar